Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization (CDMO), announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer. This press release features multimedia. View